Federal Trade Commission

The Federal Trade Commission (FTC) concerns itself with the efficacy of dietary supplements and other natural products by how the product is marketed to consumers. Here's how NPA has protected and supported the industry's right to do business in regards to the FTC:

Recent Updates from NPA Regarding FTC

Court Accepts NPA's Motion for Leave to Appear Amicus Curiae in Bayer Case (Oct. 23, 2014)

Media Clips: NPA on FTC-related Topics

Bayer, FTC Clash Over Advertising Claims (Dec. 30, 2014)
Judge Orders Mediation in Bayer/FTC Litigation, Private Plaintiffs Want Documents (Nov. 10, 2014)
CRN & NPA Call for Flexible Substantiation Standard for Supplements (Nov. 3, 2014)

 Upcoming Bayer Case

The Natural Products Association (NPA) has been granted Leave to Appear Amicus Curiae by the U.S. District Court of New Jersey in United States of America v. Bayer Corporation. NPA challenged legal action by the FTC and the Department of Justice (DOJ) against Bayer for its marketing of its Phillips’ Colon Health product in an amicus brief filed with the U.S. Supreme Court and the U.S. Attorney’s Office for the District of New Jersey:

This news comes shortly after the Department of Justice (DOJ) responded to NPA by requesting the court not accept the amicus brief: Government Opposition to NPA Motion for Leave

June 17, 2014 Senate Committee Hearing

On behalf of NPA, Dr. Fabricant appeared before the Senate Subcommittee on Consumer Protection, Product Safety and Insurance during the hearing, "Protecting Consumers from False and Deceptive Advertising of Weight-Loss Products." View NPA's Testimony to the Senate Commerce Committee.